GOJO Industries, a leading global producer and marketer of skin health and hygiene solutions and the inventors of PURELL™, announces the introduction of its latest formulation, PROVON® Antimicrobial Foam Handwash with 2% Chlorhexidine Gluconate (CHG). This new formulation is one of the most effective and gentle soap formulations GOJO has launched into the healthcare market to date.
This new formulation, which exceeds the FDA Healthcare Personnel Handwash requirements, is gentle on hands making it mild enough for everyday use. This non-irritating, hypoallergenic, dermatologist-tested formulation maintains the skin’s natural moisture barrier. PROVON Antimicrobial Foam Handwash with 2% CHG also:
• Is fragrance and dye free
• Leaves hands feeling clean and soft
• Rinses quickly with no sticky, tacky residue
• Is compatible with latex gloves
“We are committed to developing safe and effective hand hygiene products,” said Jeff Hall, healthcare business vice president and general manager, GOJO. “This CHG formulation delivers strong germ kill as well as an unexpected mildness not usually associated with CHG handwashes and surgical scrubs. We know hand hygiene plays a critical role in protecting patient safety and reducing germ transmission, but practicing good hand hygiene can be difficult on your hands when you are not using the right products. This is why we continue to advance the science of hand hygiene and develop products that are efficacious and maintain skin health. This newest formulation is an example of this commitment.”
GOJO offers a full portfolio of safe and effective hand hygiene solutions including antimicrobial and non-antimicrobial soaps and PURELL® Advanced Hand Sanitizer, as well as the world’s largest portfolio of green certified soaps and hand sanitizers, which provides healthcare facilities the benefit of choosing the best hand hygiene solution to meet their needs.
Source: GOJO Industries
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.